DNX Biopharmaceuticals Alternatives & Competitors
12 companies similar to DNX Biopharmaceuticals — Pioneering the future of medicine with innovative and long-lasting therapeutic p...
Companies similar to DNX Biopharmaceuticals
Alzprotect SAS
Therapeutic Solutions for Neurodegeneration
Loos, France
AN2 Therapeutics
Developing therapies for rare, chronic, and serious infectious diseases
Menlo Park, United States
Centrexion Therapeutics Corp.
We aim to relieve the suffering associated with chronic pain by creating treatments that a...
Boston, United States
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Rival Readout
Competing with DNX Biopharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Oak Bay Biosciences, Inc.
Developing Next-Generation Therapies for Inherited Retinal Diseases
Canada
Cullgen Inc.
Powering protein degradation for tomorrow's medicines
San Diego, United States
Gossamer Bio
Vision * Connection * Innovation
San Diego, United States
Lyndra Therapeutics
What if we stopped trying to change the patient and changed the pill instead?
Watertown, United States
PROTEINA
Our Protein-protein interaction (PPI) analysis platform enables quantitative measurements...
Seoul, Korea South
Avexxin
Crafting innovative treatments rooted in over a decade of research into inflammatory disea...
Booster Therapeutics
Pioneering proteasome therapeutics for a new approach to complex disease
Berlin, Germany
OrganoTherapeutics
Using Midbrain Organoids for the development of new Therapeutics against Parkinson`s Disea...
Luxembourg
About DNX Biopharmaceuticals
DNX Biopharmaceuticals is a biopharmaceutical company based in Irvine, CA, aiming to revolutionize the field of medicine by introducing innovative and long-lasting therapeutic proteins to combat chronic diseases. Established in 2014, DNX is dedicated to developing long-acting therapeutic proteins using a cutting-edge h...
Biopharmaceutical Company, Therapeutic Proteins, Chronic Diseases, PASylation Technology, Half-life Extension, Biotech Innovation, Long-acting Treatments, XL-protein GmbH, Global Licensing, Drug Development, Chronic Disease Management, Biomedical Research, Life-long Diseases, Pharmaceutical Technology
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around DNX Biopharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at DNX Biopharmaceuticals on 13 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
